These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33044945)

  • 1. Target RNA modification for epigenetic drug repositioning in neuroblastoma: computational omics proximity between repurposing drug and disease.
    Ma P; Yue L; Zhang S; Hao D; Wu Z; Xu L; Du G; Xiao P
    Aging (Albany NY); 2020 Oct; 12(19):19022-19044. PubMed ID: 33044945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL1 promotes neuroblastoma development through m
    Huang Y; Ma J; Yang C; Wei P; Yang M; Han H; Chen HD; Yue T; Xiao S; Chen X; Li Z; Tang Y; Luo J; Lin S; Huang L
    Biomark Res; 2022 Sep; 10(1):68. PubMed ID: 36071474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel risk signature that combines 10 long noncoding RNAs to predict neuroblastoma prognosis.
    Gao L; Lin P; Chen P; Gao RZ; Yang H; He Y; Chen JB; Luo YG; Xu QQ; Liang SW; Gu JH; Huang ZG; Dang YW; Chen G
    J Cell Physiol; 2020 Apr; 235(4):3823-3834. PubMed ID: 31612488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease.
    Lee SY; Song MY; Kim D; Park C; Park DK; Kim DG; Yoo JS; Kim YH
    Front Pharmacol; 2019; 10():1653. PubMed ID: 32063857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
    Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
    Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining.
    Liu TP; Hsieh YY; Chou CJ; Yang PM
    R Soc Open Sci; 2018 Nov; 5(11):181321. PubMed ID: 30564416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of m6A-related lncRNA signature in neuroblastoma.
    Li L; Chen S; Li J; Rong G; Yang J; Li Y
    Front Pediatr; 2022; 10():927885. PubMed ID: 36324814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma.
    Wang Z; Cheng H; Xu H; Yu X; Sui D
    Cancer Biomark; 2020; 28(3):275-284. PubMed ID: 32176634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive evaluation of connectivity methods for L1000 data.
    Lin K; Li L; Dai Y; Wang H; Teng S; Bao X; Lu ZJ; Wang D
    Brief Bioinform; 2020 Dec; 21(6):2194-2205. PubMed ID: 31774912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.
    Crosswell HE; Dasgupta A; Alvarado CS; Watt T; Christensen JG; De P; Durden DL; Findley HW
    BMC Cancer; 2009 Nov; 9():411. PubMed ID: 19939254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIAT Is an Upstream Regulator of NMYC and the Disruption of the MIAT/NMYC Axis Induces Cell Death in
    Feriancikova B; Feglarova T; Krskova L; Eckschlager T; Vicha A; Hrabeta J
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma.
    Hua Y; Gorshkov K; Yang Y; Wang W; Zhang N; Hughes DP
    Cancer; 2012 Oct; 118(20):5140-54. PubMed ID: 22415601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Five-RNA-Based Signature and Identification of Candidate Drugs for Neuroblastoma.
    Zhang P; Ma K; Ke X; Liu L; Li Y; Liu Y; Wang Y
    Front Genet; 2021; 12():685646. PubMed ID: 34745201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of the molecular characteristics of the tumor-immune interaction and the development of an individualized immune prognostic signature for neuroblastoma.
    Jin W; Zhang Y; Liu Z; Che Z; Gao M; Peng H
    J Cell Physiol; 2021 Jan; 236(1):294-308. PubMed ID: 32510620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma.
    Yu Y; Zeng Y; Xia X; Zhou JG; Cao F
    Cancer Control; 2021; 28():10732748211033751. PubMed ID: 34569303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.
    Krona C; Ejeskär K; Abel F; Kogner P; Bjelke J; Björk E; Sjöberg RM; Martinsson T
    Oncogene; 2003 Apr; 22(15):2343-51. PubMed ID: 12700669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma.
    Zhou JG; Liang B; Jin SH; Liao HL; Du GB; Cheng L; Ma H; Gaipl US
    Front Oncol; 2019; 9():1361. PubMed ID: 31867276
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of DNA microarray analysis of human neuroblastomas.
    Ohira M; Oba S; Nakamura Y; Hirata T; Ishii S; Nakagawara A
    Cancer Lett; 2005 Oct; 228(1-2):5-11. PubMed ID: 15936139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma.
    Islam A; Kageyama H; Takada N; Kawamoto T; Takayasu H; Isogai E; Ohira M; Hashizume K; Kobayashi H; Kaneko Y; Nakagawara A
    Oncogene; 2000 Feb; 19(5):617-23. PubMed ID: 10698506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA proximity sequencing data and analysis pipeline from a human neuroblastoma nuclear transcriptome.
    Wingett SW; Andrews S; Fraser P; Morf J
    Sci Data; 2020 Jan; 7(1):35. PubMed ID: 31992717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.